Research Report on China Swine Fever Vaccine Industry, 2014-2018

50 pages report Published in
Pharmaceuticals
Publisher: China Research and Intelligence

arrowFor This Report

China is the world’s largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one of the necessary vaccines for pigs. Due to the mature technology of swine fever vaccines in China, most largescale pig farms choose domestic vaccines instead of imported vaccines. There are 48 manufacturers of spleen neisseria vaccines and cell vaccines in China, including 32 for the former and 41 for the latter. Passaging cell vaccines used to be produced by Guangdong Winsun Pharmaceutical Co., Ltd. Through technology transfer, Dahuanong and Liaoning Yikang Biology Co.,Ltd. began to produce the products while Guangdong Winsun still leads in the industry.

According to the National Compulsory Immunization Plan of Animal Epidemic Diseases in China in 2013 issued by the Ministry of Agriculture of China, China implements compulsory immunity on four animal epidemic diseases including swine fever while the expenses on the vaccines are undertaken by the government.

With the increasing living standards of Chinese people, the demand for poultry meat keeps growing accordingly. However, as swine fever repeatedly occurs in China, either regional outbreak or scattered transmission, most of the cases are acute epidemic situations with high mortality rate. Meanwhile, some features of mild diseases add to the complexity of the swine fever epidemic situation. Under the circumstances, swine fever vaccines become increasingly popular while many competitive vaccine manufacturers began to develop more effective swine fever vaccines.

As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of swine fever vaccines will continue to increase in China in the next few years. Many investment opportunities exist in China for manufacturers of animal vaccines.

Through this report, the readers can acquire the following information:

  • Incidence Status of Swine Fever
  • Status of China Breeding Industry
  • Policy Environment and Government Procurement of Swine Fever Vaccines in China
  • Status of Supply and Demand for Swine Fever Vaccines in China
  • Major Manufacturers of Swine Fever Vaccines and the Operation Status in China
  • Prospect of China Swine Fever Vaccine Industry

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers and Trading Enterprises of Animal Vaccines
  • Breeding Enterprises
  • Management Organizations of Livestock Industry
  • Investors and Research Institutes Concerned about Swine Fever Vaccine Industry

Table of Contents

1 Status of Global and China Swine Fever Vaccine Market
1.1 Relevant Concepts of Swine Fever Vaccines
1.1.1 Definition of Swine Fever
1.1. Definition of Swine Fever Vaccines
1.2 Brief Introduction of Swine Fever
1.2.1 Incidence Status of Swine Fever
1.2.2 Epidemic Situation of Swine Fever in China

2 Factors Influencing Development of Swine Fever Vaccine Industry in China, 2009-2014
2.1 Policies in China Animal Vaccine Industry
2.1.1 Legislation of Animal Epidemic Prevention
2.1.2 Organization Structure
2.1.3 Appropriation Budget of Epidemic Prevention
2.1.4 Scope of Compulsory Immunization
2.1.5 Swine Fever Immunization Policies
2.2 Overview of Pig Breeding in China, 2009-2013
2.2.1 Livestock Volume of Pigs
2.2.2 Stock Volume of Fattened Pigs
2.2.3 Output Volume of Pork

3 Operation Status of Swine Fever Vaccine Industry in China, 2009-2013
3.1 Supply of Swine Fever Vaccines
3.1.1 Supply Overview
3.1.2 Factors Influencing Supply
3.2 Demand
3.2.1 Demand Overview
3.2.2 Factors Influencing Demand
3.3 Status of Free Swine Fever Vaccines Provided by Government
3.3.1 Analysis of Existing Problems
3.3.2 Solutions to Problems

4 Major Manufacturers of Swine Fever Vaccines in China, 2011-2013
4.1 Guangdong Winsun Pharmaceutical Co., Ltd.
4.1.1 Enterprise Profile
4.1.2 Production Status of Swine Fever Vaccines
4.1.3 Development Strategies of the Enterprise
4.2 Guangdong Dahuanong Animal Health Products Co., Ltd.
4.2.1 Enterprise Profile
4.2.2 Production Status of Swine Fever Vaccines
4.2.3 Development Strategies
4.3 Liaoning Yikang Biology Co., Ltd.
4.3.1 Enterprise Profile
4.3.2 Production Status of Swine Fever Vaccines
4.3.3 Development Strategies
4.4 China Animal Husbandry Industry Co., Ltd. (CAHIC)
4.4.1 Enterprise Profile
4.4.2 Production Status of Swine Fever Vaccines
4.4.3 Development Strategies

5 Status of Swine Fever Vaccine Purchase by Some Local Governments in China, 2013-2014
5.1 Bid Winning Status of Swine Fever Vaccines in Shandong, 2013-2014
5.1.1 Bid Winning Enterprises and Products of Swine Fever Vaccines
5.1.2 Bid Winning Prices
5.2 Bid Winning Status of Swine Fever Vaccines in Shanxi, 2013-2014
5.2.1 Bid Winning Enterprises and Products of Swine Fever Vaccines
5.2.2 Bid Winning Prices

6 Prospect of China Swine Fever Vaccine Industry, 2014-2018
6.1 Factors Influencing Development
6.1.1 Government Policies
6.1.2 Pig Breeding
6.2 Forecast on Supply and Demand
6.2.1 Forecast on Supply of Swine Fever Vaccines
6.2.2 Forecast on Demand for Swine Fever Vaccines

List of Charts

Chart Epidemic Situation of Swine Fever in China, 2012-2014
Chart Expenses of Chinese Government on Animal Epidemic Prevention, 2009-2014
Chart Volume of Fattened Pigs in China, 2009-2013
Chart Major Types of Swine Fever Vaccines in China
Chart Market Size of Swine Fever Vaccines in China, 2009-2013
Chart Forecast on Output Volume of Swine Fever Vaccines in China, 2014-2018
Chart Forecast on Market Size of Swine Fever Vaccines in China, 2014-2018

Related Reports

  • Research Report on China Swine Fever Vaccine Industry, 2013-2017Swine fever is an acute, hyperpyretic and contagious disease, caused by swine fever viruses. Its incidence rate and death rate are both extremely high, and viruses can be transmitted at high speed. Immunization is the major measure to prevent swine fever. With the development of Chinese economy and increasing living standards of Chinese people, the demand for pork keeps growing accordingly. In 2012, the output volume of pork in China was 53.35 million tons, increasing by 5.6% YOY. […]
  • Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2013-2017In China, PRRS is the most serious disease that impairs the pig raising & breeding industry. It inflicted heavy losses on China pig raising & breeding industry for many times. In April 2007, Ministry of Agriculture of China issued Technical Standards of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Prevention and Treatment, and classified HP-PRRS into serious animal epidemic diseases which are covered by the national compulsory immunization program. Based […]
  • Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry, 2014-2018China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of hogs was 474.11 million, down by 0.4% compared to 2012. The stock volume of fattened hogs was […]
  • Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate […]
  • Research on China Animal Vaccine Industry, 2015From 2001, FMD, HPAI, PRRS and Swine were respectively been included in compulsory immunity vaccines, meanwhile, China’s animal vaccine industry experienced a rapid development with a CAGR of 19.2 from 2000 to 2014. Currently the market size of China’s animal vaccine industry has exceeded RMB 9 billion, which mainly formed up by pig and poultry vaccines with a respectively market share of 49% and 40% in 2014. FMD Vaccine: Currently there are only 7 enterprises received the […]